S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Is Gold Really Boring? (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Is Gold Really Boring? (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Is Gold Really Boring? (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Is Gold Really Boring? (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
NASDAQ:CHB

Global X China Biotech Innovation ETF (CHB) Price, Holdings, & News

$6.64
0.00 (0.00%)
(As of 02/20/2024 ET)
Today's Range
$6.64
$6.64
50-Day Range
$6.64
$8.17
52-Week Range
$6.63
$10.07
Volume
N/A
Average Volume
712 shs
Market Capitalization
$1.39 million
Assets Under Management
$1.41 million
Dividend Yield
0.45%
Net Expense Ratio
0.67%
CHB stock logo

About Global X China Biotech Innovation ETF (NASDAQ:CHB)

The Global X China Biotech Innovation ETF (CHB) is an exchange-traded fund that is based on the Solactive China Biotech Innovation index. The fund tracks a market-cap weighted index of Chinese companies that are involved in the biotechnology industry. CHB was launched on Sep 22, 2020 and is managed by Global X.

CHB Stock Price History

CHB ETF News Headlines

This Chinese Biotech Stock Just Fell 24%
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
CHIE ETF Stock Price History
Global X China Biotech USD (9820)
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
See More Headlines
Receive CHB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X China Biotech Innovation ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Global X
Fund Name
Global X China Biotech Innovation ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:CHB
Inception Date
9/22/2020
Fund Manager
Chang Kim, Nam To, Wayne Xie, Kimberly Chan
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Solactive China Biotech Innovation Index
Category
Strategy
Focus
Theme
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
2

Fund Statistics

Assets Under Management
$1.41 million
Average Daily Volume
$0.00
Discount/Premium
-0.07%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
N/A
Short Interest
8,800 shs

Miscellaneous

Beta
0.29
Creation Unit
50,000
Creation Fee
$600.00
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Global X China Biotech Innovation ETF Expenses

TypeCHBTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.65%0.57%0.54%0.47%0.51%
Other Expenses0.02%0.72%0.54%0.33%0.58%
Total Expense0.67%0.72%0.70%0.57%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.20%-0.57%
Net Expense0.67%0.59%0.60%0.53%0.58%

Global X China Biotech Innovation ETF (CHB) Holdings

Top 10 CHB Holdings

  • WuXi Biologics (Cayman) Inc
    Holding Weight: 8.87%
  • Changchun High and New Technology Industry Group Inc Class A
    Holding Weight: 7.91%
  • Chongqing Zhifei Biological Products Co Ltd Class A
    Holding Weight: 7.71%
  • Walvax Biotechnology Co Ltd Class A
    Holding Weight: 7.60%
  • CSPC Pharmaceutical Group Ltd
    Holding Weight: 7.18%
  • Shanghai RAAS Blood Products Co Ltd Class A
    Holding Weight: 4.94%
  • Beijing Tiantan Biological Products Corp Ltd Class A
    Holding Weight: 4.76%
  • Hualan Biological Engineering Inc Class A
    Holding Weight: 4.58%
  • Sichuan Kelun Pharmaceutical Co Ltd Class A
    Holding Weight: 4.33%
  • Zai Lab(NASDAQ:ZLAB)
    Holding Weight: 4.11%














CHB ETF - Frequently Asked Questions

How have CHB shares performed in 2024?

Global X China Biotech Innovation ETF's stock was trading at $8.10 at the beginning of 2024. Since then, CHB stock has decreased by 18.0% and is now trading at $6.64.
View the best growth stocks for 2024 here
.

How often does Global X China Biotech Innovation ETF pay dividends? What is the dividend yield for Global X China Biotech Innovation ETF?

Global X China Biotech Innovation ETF announced a Semi-Annual dividend on Wednesday, December 27th. Investors of record on Friday, December 29th will be given a dividend of $0.002 per share on Monday, January 8th. The ex-dividend date of this dividend is Thursday, December 28th.
Read our dividend analysis for CHB
.

What does CHB invest in?

Global X China Biotech Innovation ETF is a equity fund issued by Global X. CHB focuses on theme investments and follows the Solactive China Biotech Innovation Index. The fund's investments total to approximately $1.41 million assets under management.

What is the management fee for Global X China Biotech Innovation ETF?

Global X China Biotech Innovation ETF's management fee is 0.65% and has other expenses of 0.02%. The net expense ratio for CHB is 0.67%.

How do I buy shares of Global X China Biotech Innovation ETF?

Shares of CHB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CHB) was last updated on 2/22/2024 by MarketBeat.com Staff